Weight Loss

At a time when more than one billion people are living with obesity,GLP-1s are widely viewed as among the biggest advances in obesity treatment. But one important question is becoming harder to avoid: what happens when people stop taking them?

If you've had to decide when to start and end your daily fast for the best results, this new study may be of help. Researchers have found that as long as your fast occurs, long-term weight loss may have little to do with when you clock on and off.

Peptide may not yet be the 2026 Oxford Word of the Year, but it must surely be in the running. For those of us not immersed in this new form of chemical pop culture, what the heck are they, and what should you be aware of if you're peptide-curious?

GLP-1 drugs like Ozempic and Wegovy are already known for treating type 2 diabetes and helping with weight loss. Now, a new study suggests they may also improve some of the most difficult complications to treat in type 2 diabetes.

A once-a-day oral GLP-1 pill known as CX11 has met its dosage and efficacy goals in a trial on US patients and will now advance to its first North American Phase 3 trial. It's already cleared this final hurdle in China where it awaits approval.

A new study suggests the drug’s influence over our brain’s control systems may attenuate behaviors linked to aggression, which, given the widespread use of these pharmaceuticals, could ultimately dampen the rate of violent crime.

Scientists have identified a new way to supercharge obesity drug semaglutide by targeting key neurons. It could dramatically boost GLP-1 weight-loss power and prevent the dreaded plateaus that not even this "wonder drug" has been able to circumvent.

Could glucagon-like peptide-1 receptor agonists (GLP-1 RAs) nix the inflammation that drives asthma? Maybe, according to a large national study of more than 27,000 older adults, which was presented to scientists last week.

High-protein diets are often touted as a great way to lose weight. A new finding from a team of researchers, however, found that under certain conditions, mice on a low-protein diet converted energy-storing white fat to calorie-burning beige fat.

A new study has shown that the popular GLP-1 weight loss drug semaglutide has the power to halt, and to some extent restore, cartilage in people suffering from osteoarthritis (OA). The finding hints at a possible use of the drug beyond weight loss.

News about intermittent fasting seems to change as frequently as the apps on your phone need upgrading. Yet another new study about the eating practice seeks to put doubts to rest after rounding up data from 22 randomized clinical trials.

After a century of false starts, scientists believe they have found a way to make cells burn more energy without the dangerous side effects – and it could be a breakthrough that reshapes weight-loss and anti-aging medicine as we know it.